Fidelity International
INDV icon

Fidelity International’s Indivior Pharmaceuticals INDV Stock Holding History

Fidelity International’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,444
Closed -$427K – 819
2023
Q2 		$427K Buy
+18,444
New +$423K ﹤0.01% 719

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Fidelity International's INDV Position: Q3 2023 in Review

Fidelity International sold out of Indivior Pharmaceuticals (INDV) in Q3 2023, closing a stake of 18,444 shares — an estimated $427K sold.

Fidelity International first reported a position in INDV in Q2 2023 and held it in 1 quarter. The position peaked at $427K in Q2 2023. 76 funds tracked by Wall St. Rank hold INDV as of Q3 2023.

  • Fidelity International reported no remaining Indivior Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Fidelity International sold 18,444 Indivior Pharmaceuticals shares in Q3 2023, an estimated $427K.
  • Fidelity International first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Fidelity International's Indivior Pharmaceuticals position peaked at $427K in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2023.

Based on Fidelity International's 13F filing for Q3 2023, filed 13 Nov 2023.